BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 1284387)

  • 1. [Benign and malignant Brenner tumor of the ovary: a clinicopathological and immunohistochemical study].
    Peng ZN
    Zhonghua Bing Li Xue Za Zhi; 1992 Dec; 21(6):333-5. PubMed ID: 1284387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
    Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
    Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
    Cuatrecasas M; Catasus L; Palacios J; Prat J
    Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brenner tumor of the ovary--a clinicopathological report of 5 cases].
    Li AY; Li XL; Xing LY
    Zhonghua Zhong Liu Za Zhi; 1987 May; 9(3):218-220, 10. PubMed ID: 3447865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis.
    Soslow RA; Rouse RV; Hendrickson MR; Silva EG; Longacre TA
    Int J Gynecol Pathol; 1996 Jul; 15(3):257-65. PubMed ID: 8811388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.
    Ali RH; Seidman JD; Luk M; Kalloger S; Gilks CB
    Int J Gynecol Pathol; 2012 Nov; 31(6):499-506. PubMed ID: 23018212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual presentation of benign cystic brenner tumor with exuberant psammomatous calcifications.
    Vemavarapu L; Alatassi H; Moghadamfalahi M
    Int J Surg Pathol; 2011 Feb; 19(1):120-2. PubMed ID: 21087980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant Brenner tumor and transitional cell carcinoma of the ovary].
    Guo LN; Tang MY
    Zhonghua Bing Li Xue Za Zhi; 1990 Sep; 19(3):209-11. PubMed ID: 2279315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brenner and transitional cell tumours of the ovary. Report of three cases.
    Rantanen V; Grénman S; Kiilholma P; Salmi T; Klemi PJ
    Ann Chir Gynaecol Suppl; 1994; 208():28-32. PubMed ID: 8092766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
    Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
    Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison.
    Austin RM; Norris HJ
    Int J Gynecol Pathol; 1987; 6(1):29-39. PubMed ID: 3570630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors.
    Kondi-Pafiti A; Kairi-Vassilatou E; Iavazzo Ch; Vouza E; Mavrigiannaki P; Kleanthis Ch; Vlahodimitropoulos D; Liapis A
    Arch Gynecol Obstet; 2012 Jun; 285(6):1699-702. PubMed ID: 22198845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Yao CW; Loh SH; Cheng MF; Hsieh DS; Bai CY
    Int J Gynecol Pathol; 2006 Apr; 25(2):140-6. PubMed ID: 16633062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitional cell tumors of the ovary: a compact group with a heterogeneous histological and immunophenotypical pattern.
    Ceauşu M; Terzea D; Georgescu A; Dobrea C; Mihai M; Iosif C; Vasilescu F; Ardeleanu C
    Rom J Morphol Embryol; 2008; 49(4):513-6. PubMed ID: 19050800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brenner tumor of the ovary: a comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder.
    Ordóñez NG; Mackay B
    Ultrastruct Pathol; 2000; 24(3):157-67. PubMed ID: 10914427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological features of ovarian Brenner tumors].
    Zhong PP; Zhu L; Zhang LH; Zheng XZ; Chen TB; Xu F; Zhan Y; Yin CH; Jin YL
    Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):615-619. PubMed ID: 31422592
    [No Abstract]   [Full Text] [Related]  

  • 17. Borderline and malignant Brenner tumours of the ovary. A report of 15 cases.
    Hallgrìmsson J; Scully RE
    Acta Pathol Microbiol Scand Suppl; 1972; 233():56-66. PubMed ID: 5074634
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective expression of cytokeratin polypeptides in various epithelia of human Brenner tumor.
    Lifschitz-Mercer B; Czernobilsky B; Shezen E; Dgani R; Leitner O; Geiger B
    Hum Pathol; 1988 Jun; 19(6):640-50. PubMed ID: 2454213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Brenner tumor of the ovary. Report of three cases.
    Ryback BJ; Ober WB; Bernacki EG
    Diagn Gynecol Obstet; 1981; 3(1):61-74. PubMed ID: 7215126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis, prognostic factors, and clinical treatment of proliferative Brenner tumor of the ovary.
    Hermanns B; Faridi A; Rath W; Füzesi L; Schröder W
    Ultrastruct Pathol; 2000; 24(3):191-6. PubMed ID: 10914431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.